Bowel Disease
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Nihon PharmaceuticalJapan - Osaka
2 programs2
NPO-13Phase 21 trial
NPO-13: l-mentholPhase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Nihon PharmaceuticalNPO-13: l-menthol
Nihon PharmaceuticalNPO-13
Clinical Trials (2)
Total enrollment: 290 patients across 2 trials
Study of NPO-13 During Colonoscopy
Start: Aug 2019Est. completion: Mar 2020158 patients
Phase 2Completed
Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy
Start: Oct 2014Est. completion: Mar 2015132 patients
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.